Previously, it has been demonstrated that a higher CD8+ T cell infiltrate in the skin is correlated with better prognosis in patients across plaque-stage MF, tumor stage MF, and CD30- PCTCL, and is correlated with less aggressive disease [24]. This evidence concerns the gene CD8A and mycosis fungoides.